204 related articles for article (PubMed ID: 7837215)
1. Lisinopril versus slow release nifedipine in patients with essential hypertension: a multicentre study.
Predel HG; Kramer HJ
J Hum Hypertens; 1994 Oct; 8(10):777-80. PubMed ID: 7837215
[TBL] [Abstract][Full Text] [Related]
2. Lisinopril versus slow-release nifedipine in the treatment of mild to moderate hypertension: a multicentre study. The Cooperative Study Group.
Witchitz S; Serradimigni A
J Hum Hypertens; 1989 Jun; 3 Suppl 1():29-33. PubMed ID: 2550643
[TBL] [Abstract][Full Text] [Related]
3. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive efficacy of a slow release nifedipine tablet formulation given once daily in patients with mild to moderate hypertension. A placebo-controlled, double-blind parallel-group trial.
Harder S; Rietbrock S; Thürmann P
Arzneimittelforschung; 1994 Feb; 44(2):133-6. PubMed ID: 8147945
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of lisinopril and nifedipine retard in essential hypertension: a double-blind, placebo-controlled trial.
Richardson PJ; Meany TB; Johnston GD; Kondowe G; Grimmer SF; Breckenridge AM
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S96-8. PubMed ID: 2455154
[TBL] [Abstract][Full Text] [Related]
6. Perindopril plus nifedipine versus perindopril plus hydrochlorothiazide in mild to severe hypertension: a double-blind multicentre study. The Multicentre Study Group on Treatment Association with Perindopril.
Letellier P; Overlack A; Agnes E; Desche P
J Hum Hypertens; 1994 Feb; 8(2):145-9. PubMed ID: 8207741
[TBL] [Abstract][Full Text] [Related]
7. A study of the effects of lisinopril when used in addition to atenolol.
Soininen K; Gerlin-Piira L; Suihkonen J; Kyllönen T; Parviainen R; Kyllönen E; Hämäläinen K; Lonka R; Tikkanen T; Selonen R
J Hum Hypertens; 1992 Aug; 6(4):321-4. PubMed ID: 1331443
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study.
O'Donnell MJ; Rowe BR; Lawson N; Horton A; Gyde OH; Barnett AH
J Hum Hypertens; 1993 Aug; 7(4):333-9. PubMed ID: 8410924
[TBL] [Abstract][Full Text] [Related]
9. Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine.
Agardh CD; Garcia-Puig J; Charbonnel B; Angelkort B; Barnett AH
J Hum Hypertens; 1996 Mar; 10(3):185-92. PubMed ID: 8733038
[TBL] [Abstract][Full Text] [Related]
10. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial.
Leonetti G;
Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895
[TBL] [Abstract][Full Text] [Related]
11. ACE inhibitors in mild to moderate hypertension: comparison of lisinopril and captopril administered once daily. French Cooperative Study Group.
Gosse P; Dallocchio M; Gourgon R
J Hum Hypertens; 1989 Jun; 3 Suppl 1():23-8. PubMed ID: 2550642
[TBL] [Abstract][Full Text] [Related]
12. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.
Svetkey LP; Weinberger MH; Gavras H; Gavras I; Brown TS; Deterding J; Klotman PE
J Clin Hypertens; 1987 Dec; 3(4):579-88. PubMed ID: 3330988
[TBL] [Abstract][Full Text] [Related]
13. Comparative trial of lisinopril and nifedipine in mild to severe essential hypertension.
Mörlin C; Baglivo H; Boeijinga JK; Breckenridge AM; Clement D; Johnston GD; Klein W; Kramer R; Luccioni R; Meurer KA
J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S49-52. PubMed ID: 2442552
[TBL] [Abstract][Full Text] [Related]
14. Effects of amlodipine and lisinopril on left ventricular mass and diastolic function in previously untreated patients with mild to moderate diastolic hypertension.
Beltman FW; Heesen WF; Smit AJ; May JF; de Graeff PA; Havinga TK; Schuurman FH; van der Veur E; Lie KI; Meyboom-de Jong B
Blood Press; 1998 May; 7(2):109-17. PubMed ID: 9657538
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy and tolerability of an angiotensin converting enzyme inhibitor (lisinopril) versus a calcium channel antagonist (diltiazem SR) in the treatment of moderate to severe hypertension.
Weir MR; Fagan T; Chrysant S; Flamenbaum W; Kaihlanen PM; Lueg M; Anzalone D
J Hum Hypertens; 1994 Jul; 8(7):531-7. PubMed ID: 7932518
[TBL] [Abstract][Full Text] [Related]
16. Lisinopril in essential hypertension: a six month comparative study with nifedipine.
Richardson PJ; Meany B; Breckenridge AM; Grimmer SF; Johnston GD; Kondowe G
J Hum Hypertens; 1987 Dec; 1(3):175-9. PubMed ID: 2852252
[TBL] [Abstract][Full Text] [Related]
17. [The effect of diltiazem and nifedipine in persons with essential hypertension].
Simić D; Jurman V
Lijec Vjesn; 1990; 112(5-6):168-71. PubMed ID: 2233115
[TBL] [Abstract][Full Text] [Related]
18. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
Misra KP; Joglekar SJ; Mukherjee S; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():30-40. PubMed ID: 11233385
[TBL] [Abstract][Full Text] [Related]
19. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacy and safety of trandolapril and nifedipine SR in mild-to-moderate hypertension. Investigator Study Group.
Steiner G; Pauly NC
J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S81-5. PubMed ID: 7527108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
